Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
Multi-Stay Study with Follow ups
Study Number8491-642 G4
Age18 - 70
Study DatesOct. 11, 2022 - Feb. 24, 2023
Labcorp Dallas, TX is recruiting for:
- Healthy Non-Smoking Adults, age 18-70
- Body Mass Index between 27-40
- Study involves 4 separate stays of 5 nights, plus 13 follow-up visits
- Compensation up to $17,062 may be provided for time and participation
- Receive up to $200 per qualified participant
The purpose of this part of the study is to evaluate how much midazolam a drug used as a short-acting sedative, warfarin a drug used as a blood thinner, caffeine a drug used for mental alertness and migraine headaches, and their breakdown products get into the bloodstream after receiving multiple subcutaneous (under the skin) doses of the study drug.
Call Now to Schedule Your Screening Appointment!
Check-in: Oct 11, Dec 2, Dec 30, Jan 27
Check-out: Oct 16, Dec 7, Jan 4, Feb 1
OPV: Oct 21, 28, Nov 4, 11, 18, 25, Dec 9, 16, 23, Jan 6, 13, Feb 24